Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Rebecca Deya, MSN, RN
Research Manager
Baptist MD Anderson Clinical Trials
904.202.7468
rebecca.deya@bmcjax.com
Clinical Trial ID: NCT05481151
A Phase IIIb, Single-Arm, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Ropeginterferon alfa-2b-njft (P1101) in Adult Patients with Polycythemia Vera (PV)
Status
Open
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Norkin, Maxim
Practice
Heme
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT05481151
Secondary Trial ID Number
PV A22-203
Keywords
Treatment